Creotech Instruments Sa · GPW:CRI

Creotech Instruments Sa — Q1 2026 Earnings Presentation

9 slides from Creotech Instruments Sa's earnings presentation, June 2026

  1. Slide 1: Presentation of Financial Results for Q1 2026

    Gdzie jesteśmy Presentation of dzisiaj? Financial Results for Q1 2026 June 2026 1

  2. Slide 2: Disclaimer

    Disclaimer This presentation contains a selection and summary of Creotech Instruments S.A.’s (the “Company” or the “Issuer”) financial and operational results for the first quarter of 2026 (Q1 2026). It does not constitute a complete set of financial statements and should not be relied upon as such.

  3. Slide 3: Q1 2026 Summary – Figures for Continuing Operations

    Q1 2026 Summary – Figures for Continuing Operations ORDER BACKLOG Q1 2026 CASH BALANCE AS OF THE END The first quarter of 2026 OF Q1 2026 proceeded fully in line with our project execution PLN ~587.0 M PLN 74.2 M schedule. b) OPERATING REVENUE Q1 2026: Vs PLN 115M as of the end of Q4 2025 a) PLN 18M

  4. Slide 4: Order Backlog

    Order Backlog +37x in two years Backlog of ~PLN 587M, broadly stable vs year - end 2025. PLN 596M + new contracts (offsetting) Grew from PLN 16M (end - 2023) to PLN 587M (end - 2025), PLN 16. 6 M driven by the Mikroglob (PLN 452M) and CAMILA (~EUR 59M) PLN 474M Q1 revenue prime contractor awards. In

  5. Slide 5: Space Projects Segment Financials

    Space Projects Segment Financials Revenue (PLN M) EBITDA (PLN M) Operating revenue fell from PLN 20.4M in Q1 2025 to PLN 16.9M in Q1 2026 EBITDA stood at PLN 0.5M vs. PLN 7.9M year - over - year 20.4 Milestone - based revenue recognition:​ 16.9 The Company’s financial profile in Q1 2026 reflects the

  6. Slide 6: Key Financial Indicators – Figures for Continuing Operations

    Key Financial Indicators – Figures for Continuing Operations Q1’25 Q1’26 Operating revenue 21.7 18.0 Total operating revenue declined - 17% YoY to PLN 18.0M, Operating expenses 18.7 28.4 driven by the timing of project milestones rather than any Operating profit 3.0 - 10.5 reduction in business scal

  7. Slide 7: Investing Cashflow

    Investing Cashflow CapEx of PLN 6.8M in Q1 2026 vs PLN 12.7M in Q1 2025. 15 12.7 The Company continues to invest in expanding production capacity and R&D infrastructure, in line with its Strategy 2026 – 2029. 10 Investment is expected to scale up as growth initiatives are deployed — a key area for i

  8. Slide 8: Balance Sheet – Figures for Continuing and Discontinued Operations

    Balance Sheet – Figures for Continuing and Discontinued Operations Q4’25 Q1’26 Cash bridge. Cash decreased from PLN 126.9M to PLN Non - current assets 119.7 133.7 83.9M, mainly reflecting negative operating cash flow of PP&E 38.7 41.1 PLN - 36.4M (lower trade payables and a build - up in Intangible

  9. Slide 9: Thank you for your attention!

    Thank you for your attention ! CONTACT FOR INVESTORS: inwestor@creotech.pl www.creotech.pl 9

Creotech Instruments — Q1 2026 Earnings Presentation on 6ix